Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Evoqua Water Technologies Rises On Better-than-expected Results
-
Binance CEO CZ Explains What Tesla’s Q2 2022 $BTC Sales Means for Bitcoin
-
Bitcoin's Surging Transaction Fees Viewed As “Direct Attack” By A Cross-Section Of The Community
-
Markets Wait For Jobs Data From The U.S.
-
Green Dot Corp. Drops 10% As Profit, Revenue Decline In Q2